Cite
HARVARD Citation
Zhou, L. et al. (2022). Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy. Melanoma research. 32 (3), pp. 142-149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, L. et al. (2022). Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy. Melanoma research. 32 (3), pp. 142-149. [Online].